Adam Brown, DPM
Foot & Ankle Surgery · Reseda, CANPI 1629475165
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,893 of the $6,594 with a category attached, or 89.4%. 23 manufacturers reported payments, led by Musculoskeletal Transplant Foundation Inc. at 42.5% of the total. Reporting peaked in 2020 at $3,019 and has fallen 65.7% since, to $1,036 in 2025.
Across 133 payments — averaging $49.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$3K
- Paratek Pharmaceuticals, Inc.$1K
- Smith+Nephew$809
- Amgen$519
- Nevro Corp.$319
- Melinta Therapeutics, LLC$212
- plus $765 from 17 others
Across 9 payments — averaging $5075.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Royal Biologics, Inc.$46K
What the payments were for
- Travel & lodging$70111%
- Food & beverage$5,89389%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 4 | $2,803 |
| Paratek Pharmaceuticals, Inc. | 45 | $1,167 |
| Smith+Nephew | 32 | $809 |
| Amgen | 13 | $519 |
| Nevro Corp. | 5 | $319 |
| Melinta Therapeutics, LLC | 5 | $212 |
| Cardiovascular Systems Inc. | 3 | $160 |
| Solventum Corporation | 2 | $109 |
| KCI USA, Inc. | 5 | $98 |
| GRT US Holding, Inc. | 2 | $61 |
| Organogenesis Inc. | 2 | $48 |
| Curonix LLC | 2 | $45 |
| Tactile Systems Technology Inc | 2 | $35 |
| Convatec Inc. | 2 | $27 |
| Apria Healthcare LLC | 1 | $24 |
| Stryker | 1 | $22 |
| Hartmann USA, Inc. | 1 | $22 |
| Kerecis Limited | 1 | $21 |
| Integra Lifesciences Corporation | 1 | $20 |
| Medical Device Business Services, Inc. | 1 | $20 |
| Medela LLC | 1 | $19 |
| Averitas Pharma Inc. | 1 | $18 |
| Nabriva Therapeutics, PLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUZYRA$500
- KRYSTEXXA$365
- Omnia$142
- GRAFIX PL$130
- Grafix XC$130
- Stravix$130
- STRAVIX PL$130
- Peripheral Orbital Atherectomy System$125
- ACTICOAT 4" X 4"$121
- ALLEVYN HEEL 10.5CM X 13.5CM CTN 5$121
- Iodosorb Ointment 40g USA$121
- COLLAGENASE SANTYL$121
- Kimyrsa$106
How this compares
$6,594 in reported general payments places this provider in the 75th percentile of 1,126 foot & ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 61 | $2,060 |
| Ammonium Lactate | 80 | $1,166 |
| Ketoconazole | 50 | $638 |
| Oxycodone Hcl | 17 | $353 |
| Ciclopirox | 11 | $249 |
| Diclofenac Sodium | 16 | $177 |
| Triamcinolone Acetonide | 17 | $142 |
| Mupirocin | 24 | $91 |
| Terbinafine Hcl | 12 | $64 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Reseda
- Eric GizaSacramento$3.6M
- Thomas HarrisPasadena$3M
- Thomas ChangSanta Rosa$2M
- Michael CoughlinSan Francisco$1.6M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Candice BradyCamarillo$462K
- Andrew HsuOrange$456K
- Eric TanLos Angeles$447K
- Joseph ParkBurbank$387K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.